Autoimmune hemolytic anemia (AIHA) is a rare disorder in which the body's immune system attacks and destroys its own red blood cells. The prognosis of AIHA depends on the severity of the condition and the underlying cause. Generally, the outlook is good with prompt diagnosis and treatment.
Prognosis with Treatment
When AIHA is treated promptly and appropriately, the prognosis is usually good. Treatment for AIHA involves suppressing the immune system with medication and/or removing the affected red blood cells from the body. With proper treatment, most patients can expect to have a full recovery.
Prognosis without Treatment
Without treatment, AIHA can become life-threatening. It can lead to anemia, organ damage, and other medical complications. If the condition is left untreated, the prognosis is poor and the patient may even die.
Long-term Prognosis
The long-term prognosis of AIHA depends on the underlying cause. For some people, the condition may go away on its own or may be managed with ongoing treatment. For others, AIHA may be a chronic condition that requires lifelong treatment.
